ABBOTT LABORATORIES INC
ABBOTT LABORATORIES INC
Aktie · US0028241000 · ABT · 850103 (XNYS)
Übersicht Finanzkennzahlen
Kein Kurs
05.09.2025 21:26
1 Tag
-
1 Woche
-
1 Monat
-
3 Monate
-
6 Monate
-
Jahr bis heute
-
1 Jahr
-
2 Jahre
-
3 Jahre
-
4 Jahre
-
5 Jahre
-
10 Jahre
-
20 Jahre
-
Max
-
Analyst Grade Summary
gauge-img
Kaufen
Starker Kauf
Kaufen
Halten
Verkaufen
Starker Verkauf
0
29
9
0
0
Aktuelle Kurse von ABBOTT LABORATORIES INC
BörseTickerWährungLetzter UmsatzKursTagesveränderung
XNYS: NYSE
NYSE
ABT
USD
05.09.2025 21:26
133,50 USD
0,69 USD
+0,52 %
XETR: XETRA
XETRA
ABL.DE
EUR
05.09.2025 14:30
113,70 EUR
-1,12 EUR
-0,98 %
ESG-Risiko-Rating
B Gering
Free Float & Liquidität
Free Float 99,33 EUR
Shares Float 1,73 B EUR
Ausstehende Aktien 1,74 B EUR
Investierte Fonds

Folgende Fonds haben in ABBOTT LABORATORIES INC investiert:

Fonds
iShares US Medical Devices UCITS ETF USD (Acc)
Vol. in Mio
7.104,69
Anteil (%)
12,72 %
Fonds
iShares MSCI USA Islamic UCITS ETF USD (Dist)
Vol. in Mio
5.890,40
Anteil (%)
3,52 %
Fonds
iShares MSCI World Health Care Sector UCITS ETF USD (Dist)
Vol. in Mio
10.634,24
Anteil (%)
2,92 %
Fonds
iShares MSCI World Islamic UCITS ETF USD (Dist)
Vol. in Mio
6.334,12
Anteil (%)
1,93 %
Fonds
iShares Dow Jones Global Titans 50 UCITS ETF (DE)
Vol. in Mio
14.783,31
Anteil (%)
1,23 %
Firmenprofil zu ABBOTT LABORATORIES INC Aktie
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Unternehmensdaten

Name ABBOTT LABORATORIES INC
Firma Abbott Laboratories
Symbol ABT
Website https://www.abbott.com
Heimatbörse XNYS NYSE
WKN 850103
ISIN US0028241000
Wertpapierart Aktie
Sektor Healthcare
Branche Medical - Devices
CEO Robert B. Ford
Marktkapitalisierung 194 Mrd.
Land Vereinigte Staaten von Amerika
Währung USD
Mitarbeiter 114,0 T
Adresse 100 Abbott Park Road, 60064-6400 North Chicago
IPO Datum 2007-12-20
Dividenden von 'ABBOTT LABORATORIES INC'
Ex-Datum Dividende pro Aktie
15.07.2025 0,59 USD
15.04.2025 0,59 USD
15.01.2025 0,59 USD
15.10.2024 0,55 USD
15.07.2024 0,55 USD
12.04.2024 0,55 USD
11.01.2024 0,55 USD
12.10.2023 0,51 USD
13.07.2023 0,51 USD
13.04.2023 0,51 USD

Aktien-Splits

Datum Split
02.01.2013 10000:4798
03.05.2004 10000:9356
01.06.1998 2:1
01.06.1992 2:1
01.06.1990 2:1
02.06.1986 2:1
01.06.1981 2:1

Ticker Symbole

Name Symbol
Frankfurt ABL.F
NYSE ABT
SIX ABT.SW
XETRA ABL.DE
Weitere Aktien
Investoren, die ABBOTT LABORATORIES INC halten, haben auch folgende Aktien im Depot:
ADOBE INC
ADOBE INC Aktie
ALPHABET INC - CLASS A
ALPHABET INC - CLASS A Aktie
AMAZON.CO INC
AMAZON.CO INC Aktie
APPLE INC
APPLE INC Aktie
AVISTA CORP
AVISTA CORP Aktie
BLACKROCK  INC - CLASS A
BLACKROCK  INC - CLASS A Aktie
DWS I.-TOP EUROLAND NC
DWS I.-TOP EUROLAND NC Fonds
DZ BANK      CLN E.9902
DZ BANK CLN E.9902 Anleihe
MICROSOFT CORP
MICROSOFT CORP Aktie
NVIDIA CORP
NVIDIA CORP Aktie
PAYPAL INC
PAYPAL INC Aktie
TESLA INC
TESLA INC Aktie
Vienatix GmbH
Vienatix GmbH Asset
VISA INC - CLASS A
VISA INC - CLASS A Aktie
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios. Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Impressum Datenschutz Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025